Detalhe da pesquisa
1.
Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV.
Blood
; 126(1): 42-9, 2015 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25918346
2.
Recruitment of platelets, white blood cells, and hematopoietic progenitor cells during high-yield plateletpheresis.
Transfusion
; 51(9): 2034-43, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21438883
3.
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis.
Nat Commun
; 8(1): 593, 2017 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28928446
4.
Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
Clin Cancer Res
; 11(4): 1416-24, 2005 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15746041
5.
Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non-Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09.
Clin Lung Cancer
; 16(5): 358-65, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25843489
6.
Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus.
Nat Genet
; 44(3): 338-42, 2012 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22267198
7.
Deregulated expression of Kruppel-like factors in acute myeloid leukemia.
Leuk Res
; 35(7): 909-13, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21470678
8.
NDRG1/2 expression is inhibited in primary acute myeloid leukemia.
Leuk Res
; 34(3): 393-8, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19775754
9.
Reference materials (RMs) for analysis of the human factor II (prothrombin) gene G20210A mutation.
Clin Chem Lab Med
; 43(8): 862-8, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16201898